Prof. Raymond Tjandrawinata Ranked Among the World's Top 1,000 Scientists

Years of dedication to research and scientific advancement have earned Prof. Raymond R. Tjandrawinata, Molecular Pharmacologist at Dexa Group, a place among the top 7.9% of researchers in the Top 1000Scholar 2026 ranking, under the Diverse Scientific Research Studies (Biomedical, Law and Theology) category, with an H index of 29.

Within this category, Prof. Raymond achieved an Impact Score of 80.76, placing him in the top 7.9% of researchers. His academic achievements include 266 scientific publications, 3,279 citations, and an H-index of 29. He also ranked first in Indonesia and 107th worldwide in the Tannin, Tannase and Anticancer Activities category.

"This ranking recognizes years of research involving numerous scientists, institutions, and collaborators. A strong research ecosystem, skilled professionals, and adequate technological resources are essential to developing innovations that can compete on a global scale," said Prof. Raymond, who also serves as Professor of Molecular Pharmacology at Atma Jaya Catholic University of Indonesia, in Jakarta on Friday, November 6, 2026. A Scientific Journey Across Disciplines

Prof. Raymond's academic journey has taken him to NASA's Kennedy Space Center in the United States. In 1991, he participated in the Spacelab Life Sciences project, which investigated physiological changes and osteoporosis in astronauts exposed to microgravity. He also gained industry experience at GlaxoSmithKline, a pharmaceutical company in California.

His academic background spans Physiology, Biochemistry, Molecular Pharmacology, and Strategic Management. In September 2026, he further expanded his academic credentials by earning a Doctor of Law degree from Pelita Harapan University, graduating Summa Cum Laude. His dissertation explored the balance between pharmaceutical patent protection and public access to medicines.

Throughout his career, Prof. Raymond has received numerous prestigious recognitions, including the Habibie Award, the WIPO Medal for Inventor, and the SINTA Award. He has also received recognition from the Indonesian Museum of Records (MURI) for his contributions to Scopus-indexed publications and interdisciplinary biomedical patents.

"Advancing healthcare innovation requires a multidisciplinary perspective. Research, business, technology, regulatory frameworks, and patient needs must work together to ensure that innovations are not only scientifically sound but also deliver tangible benefits," he explained.

Turning Indonesia's Biodiversity into Innovation Since 2005, Prof. Raymond has been working with Dexa Laboratories of Biomolecular Sciences (DLBS) to develop Integrative Natural Modern Medicine (Obat Modern Alami Integratif/OMAI). This initiative harnesses Indonesia's rich biodiversity as a foundation for pharmaceutical research and innovation, combining biotechnology with molecular pharmacology.

The development process encompasses active compound identification, standardization, safety testing, and scientific validation of efficacy. Advanced omics approaches, including genomics, proteomics, and metabolomics, further support the exploration of Indonesia's natural resources.

"Indonesia is blessed with extraordinary biodiversity. The challenge is to translate this natural wealth into innovations backed by strong scientific evidence. Natural ingredients cannot rely solely on traditional knowledge or empirical use. They must undergo rigorous research, standardization, and scientific evaluation to establish their safety and efficacy," said Prof. Raymond

This journey highlights that innovation is never the work of one individual or a single department. Researchers, laboratory personnel, Production, Quality Assurance, Regulatory Affairs, Medical Affairs, and all supporting functions play an essential role in translating research findings into high-quality healthcare products.

Building Quality Together

Prof. Raymond's achievement demonstrates that global recognition is built over time through consistent dedication, scientific expertise, a willingness to explore new possibilities, and strong collaboration.

These principles reflect Dexa Group's commitment to Cerminan Kualitas Dexa Group (Reflecting Dexa Group's Quality). Quality is defined not only by the final product but also by the dedication invested in every process and the contributions of every individual. This commitment is rooted in the company's Core Purpose: Expertise for the Promotion of Health.

"The success of research is not measured solely by the number of publications or awards received. What matters most is how knowledge is translated into innovations that address healthcare needs and create meaningful benefits for society," Prof. Raymond emphasized.

This achievement serves as an inspiration for all Dexans to keep learning, strengthen their expertise, and contribute their best. Ultimately, meaningful achievements are built through a consistent commitment to quality, stronger collaboration, and a shared dedication to improving public health.